new analysis finds that a notable portion of treatment guidelines issued in recent years by medical societies and government agencies for combating mild depression were compiled by individuals with financial conflicts of interest or lacked other safeguards to ensure impartiality.

Of 172 people who participated in 14 guidelines committees, 18 percent had ties to drug makers that sell antidepressants, and some had connections to more than one company. Five guidelines, meanwhile, recommended antidepressants as a first-line treatment for mild depression, and four of those — or 80 percent — had panelists with some type of financial connection, according to the analysis in Psychotherapy and Psychosomatics.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Most antidepressants are prescribed by primary care physicians most of whom don’t know the first thing about psychopharmacology. The patients often wind up seeing the shrink due to medication mismanagemen by the idiot GP who produces an iatrogenic serotoninergic crisis because they were unaware of the taper guidelines for SSRI’s.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.